Cargando…
Evaluation of Vancomycin Area Under the Concentration–Time Curve Predictive Performance Using Bayesian Modeling Software With and Without Peak Concentration: An Academic Hospital Experience for Adult Patients Without Renal Impairment
BACKGROUND: The revised U.S. consensus guidelines on vancomycin therapeutic drug monitoring (TDM) recommend obtaining trough and peak samples to estimate the area under the concentration–time curve (AUC) using the Bayesian approach; however, the benefit of such two-point measurements has not been de...
Autores principales: | Kim, Hyun-Ki, Jeong, Tae-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345177/ https://www.ncbi.nlm.nih.gov/pubmed/37387488 http://dx.doi.org/10.3343/alm.2023.43.6.554 |
Ejemplares similares
-
Clinical Relevance of a Vancomycin 24 h Area under the Concentration—Time Curve Values Using Different Renal Function Equations in Bayesian Dosing Software
por: Kim, Hyun-Ki, et al.
Publicado: (2023) -
67. Agreement Among Bayesian Dosing Software for Calculating Vancomycin Area Under the Curve
por: Pineda, Ross, et al.
Publicado: (2021) -
329. Vancomycin area under the concentration-time curve monitoring from Bayesian modeling in outpatient parenteral antimicrobial therapy
por: Gillett, Eric M, et al.
Publicado: (2023) -
Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian‐derived area under the curve in critically ill patients with cancer
por: AbuSara, Aseel K., et al.
Publicado: (2022) -
Simulation of Vancomycin Exposure Using Trough and Peak Levels Achieves the Target Area under the Steady-State Concentration–Time Curve in ICU Patients
por: Ibe, Yuta, et al.
Publicado: (2023)